PDS Biotechnology Corporation
PARTICULATE VACCINE FORMULATIONS
Last updated:
Abstract:
The present disclosure provides vaccine formulations comprising at least one peptide antigen assembly and at least one adjuvant. The disclosure also provides methods of inducing an immune response in a mammal and methods of treating a disease in a mammal utilizing the vaccine formulations.
Status:
Application
Type:
Utility
Filling date:
21 Mar 2019
Issue date:
12 Sep 2019